$16.23
-0.17-1.07%
Last update: Nov 11, 9:35 AM
Jade Biosciences Inc
JBIONASDAQ
The average analyst price target for Jade Biosciences is $46.83, 188.6% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $25 to $77. The latest change came on Aug 11, 2026, when Wedbush raised its price target on Jade Biosciences from $45 to $47 and kept an Outperform rating.
Price Target Range — 7 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
